Fenghuang Baiyunshan Pharmaceutical

Hubei Fenghuang Baiyunshan Pharmaceutical Co., Ltd. is a pharmaceutical company based in Macheng, Hubei Province, China, specializing in Traditional Chinese Medicine (TCM) and chemical drug manufacturing. Founded in 2002, the company produces a diverse portfolio of commercial drugs, including Yangxue Oral Liquid for blood enrichment, Xiaoaiping Oral Liquid for oncological care, and various respiratory treatments such as Compound Dextromethorphan Hydrobromide Syrup. The company operates modern GMP-certified facilities and is recognized for its large-scale herbal extraction capabilities. Fenghuang Baiyunshan also conducts pre-clinical research in collaboration with academic institutions to investigate the neuroprotective properties of its formulations for neurodegenerative conditions like Alzheimer's and Parkinson's disease. In 2024, the company faced regulatory investigations by the Hubei Provincial Drug Administration regarding the quality control and market distribution of certain drug batches.